Showing results (81-90 of 155) with videos related to
Sort By:
Pageof 16
Plos One|July 2, 2016
The Current Recommended Vitamin D Intake Guideline for Diet and Supplements During Pregnancy Is Not Adequate to Achieve Vitamin D Sufficiency for Most Pregnant WomenFariba Aghajafari, Catherine J Field, Bonnie J Kaplan, et al.The Journal of Clinical Endocrinology and Metabolism|July 26, 2014
Clinical review: Effect of vitamin D3 supplementation on improving glucose homeostasis and preventing diabetes: a systematic review and meta-analysisJennifer C Seida, Joanna Mitri, Isabelle N Colmers, et al.The American Journal of Medicine|November 27, 2012
Bisphosphonate therapy for osteoporosis: benefits, risks, and drug holidayMichael McClung, Steven T Harris, Paul D Miller, et al.Bone|November 27, 2013
Differing effects of denosumab and alendronate on cortical and trabecular boneRoger M Zebaze, Cesar Libanati, Matthew Austin, et al.Annals of Internal Medicine|March 7, 2007
Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trialSusan L Greenspan, Henry G Bone, Mark P Ettinger, et al.Nutrients|October 1, 2016
The VITAH Trial-Vitamin D Supplementation and Cardiac Autonomic Tone in Patients with End-Stage Kidney Disease on Hemodialysis: A Blinded, Randomized Controlled TrialMichelle C Mann, Derek V Exner, Brenda R Hemmelgarn, et al.Canadian Journal of Public Health = Revue Canadienne De Sante Publique|March 10, 2010
Health-related quality of life in Canadian adolescents and young adults: normative data using the SF-36Wilma M Hopman, Claudie Berger, Lawrence Joseph, et al.Menopause (New York, N.Y.)|June 18, 2010
Determining whether women with osteopenic bone mineral density have low, moderate, or high clinical fracture riskLisa Langsetmo, Suzanne Morin, Christopher S Kovacs, et al.Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|November 12, 2013
Understanding and communicating the benefits and risks of denosumab, raloxifene, and teriparatide for the treatment of osteoporosisE Michael Lewiecki, Paul D Miller, Steve T Harris, et al.Canadian Journal of Public Health = Revue Canadienne De Sante Publique|June 8, 2002
Is there regional variation in the SF-36 scores of Canadian adults?Wilma M Hopman, Claudie Berger, Lawrence Joseph, et al.Pageof 16